跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MIFEGYMISO - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MIFEGYMISO
Authorized
STANDARD
MIFEGYMISO
linepharma international limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e81ce616d1388495
Company
linepharma international limited
Type
Standard
Approval Details
Approval Id
e81ce616d1388495
Drug Approval Canada Name
MIFEGYMISO
Product Name
MIFEGYMISO
Status
Marketed
Status Date
2017-01-10
Original Market Date
2017-01-10
Din
02444038
Drug Class
Human
Dosage Form
Tablet , Kit
Route Of Administration
Buccal , Oral
Schedule
Prescription
Ahfs
56:28.28
Atc Original
G03XB51 MIFEPRISTONE, COMBINATIONS
Atc Name
g 03 xb 51
Aig Number
0257170001
Company Name
linepharma international limited
Company Address
16 Upper Woburn Place, London, Greater London, United Kingdom, WC1H0BS
Active Ingredients
MIFEPRISTONE
200 MG
MISOPROSTOL
200 MCG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e81ce616d1388495
Type
Standard
Back to Health Canada Approvals